333

CELL BIO HUMAN TECH

No trades
See on Supercharts
Market capitalization
‪39.53 B‬KRW
‪−1.86 B‬KRW
‪27.32 B‬KRW
‪4.02 M‬
Beta (1Y)
0.90

About CELL BIO HUMAN TECH

CEO
Kwon-Sun Lee
Headquarters
Anyang-si
Employees (FY)
60
Founded
2015
ISIN
KR7318160009
FIGI
BBG01G9GB5D0
Cell Bio Human Tech Co., Ltd. engages in the manufacture and sale of textile based cosmetic mask pack materials. It operates through the following business divisions: PT CELL, SEMI GEL, S Cell, and NC Cell. The PT CELL division offers masks made of absorbent bamboo material. The SEMI GEL division provides masks made of lyocell material with high absorbency in gel form. The S Cell division includes rayon material with a soft texture. The NC Cell refers to lyocell material with high transparency. The company was founded on July 7, 2015 and is headquartered in Anyang-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 318160 is 4245 KRW — it has decreased by 0.59% in the past 24 hours. Watch CELL BIO HUMAN TECH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CELL BIO HUMAN TECH stocks are traded under the ticker 318160.
318160 stock is 3.33% volatile and has beta coefficient of 0.90. Track CELL BIO HUMAN TECH stock price on the chart and check out the list of the most volatile stocks — is CELL BIO HUMAN TECH there?
Yes, you can track CELL BIO HUMAN TECH financials in yearly and quarterly reports right on TradingView.
318160 stock has risen by 1.31% compared to the previous week, the month change is a 7.20% rise, over the last year CELL BIO HUMAN TECH has showed a 49.88% decrease.
318160 net income for the last quarter is ‪−1.01 B‬ KRW, while the quarter before that showed ‪432.54 M‬ KRW of net income which accounts for −333.02% change. Track more CELL BIO HUMAN TECH financial stats to get the full picture.
No, 318160 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 318160 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELL BIO HUMAN TECH stock right from TradingView charts — choose your broker and connect to your account.
318160 reached its all-time high on Apr 21, 2023 with the price of 12800 KRW, and its all-time low was 3300 KRW and was reached on Oct 26, 2023. View more price dynamics on 318160 chart.
See other stocks reaching their highest and lowest prices.
As of May 4, 2024, the company has 60.00 employees. See our rating of the largest employees — is CELL BIO HUMAN TECH on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CELL BIO HUMAN TECH technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CELL BIO HUMAN TECH stock shows the strong buy signal. See more of CELL BIO HUMAN TECH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CELL BIO HUMAN TECH EBITDA is ‪4.95 B‬ KRW, and current EBITDA margin is 18.13%. See more stats in CELL BIO HUMAN TECH financial statements.